AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2015
Jan 6, 2015
35106_dirs_2015-01-05_ba47592f-6135-416e-8d21-7e45623d6c37.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2014-12-31
Reporting Person: MANCUSO FRANK G /FA/ (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | Stock Option (right to buy) | $6.50 | A | 769 | Acquired | 2024-12-31 | Common Stock (769) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.01 par value | 4667 | Direct |
Footnotes
F1: Share ownership totals have been adjusted to reflect a 1 for 75 reverse stock split effected by the issuer on October 24, 2014.
More from Predictive Oncology Inc.
Capital/Financing Update
2026
Jul 2
Capital/Financing Update
2026
Jun 9
Regulatory Filings
2026
Jun 9
Earnings Release
2026
May 15
Capital/Financing Update
2026
May 15
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 16